{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "18508447", "DateCompleted": {"Year": "2008", "Month": "09", "Day": "19"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2008", "Month": "05", "Day": "01"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1093-9946", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2008", "Month": "May", "Day": "01"}}, "Title": "Frontiers in bioscience : a journal and virtual library", "ISOAbbreviation": "Front Biosci"}, "ArticleTitle": "Dietary terpenoids and prostate cancer chemoprevention.", "Pagination": {"StartPage": "3457", "EndPage": "3469", "MedlinePgn": "3457-69"}, "Abstract": {"AbstractText": ["Cancer chemoprevention by phytochemicals may be one of the most feasible approaches for cancer control. Phytochemicals obtained from vegetables, fruits, spices, teas, herbs and medicinal plants, such as terpenoids and other phenolic compounds, have been proven to suppress experimental carcinogenesis in various organs in pre-clinical models. Recent studies have indicated that mechanisms underlying chemopreventive potential may be a combination of antioxidant, anti-inflammatory, immune-enhancing, and hormone modulation effects, with modification of drug metabolizing enzymes, influence on cell cycle and cell differentiation, induction of apoptosis, suppression of proliferation and angiogenesis playing roles in the initiation and secondary modification stages of neoplastic development. Specific features of prostate cancer, such as high prevalence and long latency period provides ample opportunities for chemopreventive agents to work at various stages of disease progression. Finally, suitable populations with appropriate risk factors, including the presence of pre-malignant lesions and genetic predispositions, need to be well characterized for future chemopreventive interventions. Here we review naturally occurring dietary terpenoids as useful agents for prostate cancer chemoprevention with reference to their classes and sources."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Urology, Case Western Reserve University, University Hospitals, University Hospitals Case Medical Center, Cleveland, Ohio 44106, USA."}], "Identifier": [], "LastName": "Rabi", "ForeName": "Thangaiyan", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gupta", "ForeName": "Sanjay", "Initials": "S"}], "GrantList": [{"GrantID": "R01 AT002709", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "R01 CA108512", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R03 CA107806", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Front Biosci", "NlmUniqueID": "9709506", "ISSNLinking": "1093-4715"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticarcinogenic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Diterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Terpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "36-88-4", "NameOfSubstance": "Carotenoids"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Anticarcinogenic Agents"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Carotenoids"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Division"}, {"QualifierName": ["methods"], "DescriptorName": "Chemoprevention"}, {"QualifierName": [], "DescriptorName": "Diet"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Diterpenes"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Phenotype"}, {"QualifierName": ["genetics", "pathology", "physiopathology", "prevention & control"], "DescriptorName": "Prostatic Neoplasms"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Terpenes"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Triterpenes"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "American Cancer Society. Cancer Statistics. 2007."}, {"Citation": "Shukla S, Gupta S. Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer. 2005;53:18\u201332.", "ArticleIdList": ["16351503"]}, {"Citation": "Gupta S. Prostate cancer chemoprevention: Current status and future prospects. Toxicol Appl Pharmacol. 2006 Nov 15; Epub ahead of print.", "ArticleIdList": ["17189645"]}, {"Citation": "Ichikawa T, Suzuki H, Ueda T. Hormone treatment for prostate cancer: current issues and future directions. Cancer Chemother Pharmacol. 2005;56:58\u201363.", "ArticleIdList": ["16273367"]}, {"Citation": "Tang DG, Porter AT. Target to apoptosis: a hopeful weapon for prostate cancer. Prostate. 1997;32:284\u2013293.", "ArticleIdList": ["9288188"]}, {"Citation": "Tannock I, de Wit R, Berry W. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer. New England Journal of Medicine. 2004;351:1502\u20131512.", "ArticleIdList": ["15470213"]}, {"Citation": "Kitagawa T, Hara M, Sano T, Sugimura T. The concept of Tenju-gann, or \u201cnatural-end cancer\u201d. Cancer. 1998;83:1061\u20131065.", "ArticleIdList": ["9740067"]}, {"Citation": "Sugimura T. An overview of cancer prevention. Eur J of Cancer Prev. 1996;5:1\u20138.", "ArticleIdList": ["9061288"]}, {"Citation": "Wattenberg LW. An overview of chemoprevention: current status and future prospects. Proc Soc Exp Biol Med. 1997;216:133\u2013141.", "ArticleIdList": ["9349682"]}, {"Citation": "Greenwald P, Milner JA, Anderson DE, McDonald SS. Micronutrients in cancer chemoprevention. Cancer Metastasis Rev. 2002;21:217\u2013230.", "ArticleIdList": ["12549762"]}, {"Citation": "Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci USA. 1995;92:5258\u20135265.", "ArticleIdList": ["PMC41674", "7777494"]}, {"Citation": "Tanaka T, Kohno H, Mori H. Chemoprevention of colon carcinogenesis by dietary non-nutritive compounds. Asian Pac J Cancer Prev. 2001;2:165\u2013177.", "ArticleIdList": ["12718627"]}, {"Citation": "Wattenberg LW. Chemoprevention of cancer. Prev Med. 1996;25:44\u201345.", "ArticleIdList": ["8778762"]}, {"Citation": "Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N, Moore MA. Cancer prevention by natural compounds. Drug Metab Pharmacokin. 2004;19:245\u2013263.", "ArticleIdList": ["15499193"]}, {"Citation": "Anne S, Tsao, Edwards S, Kim, Hong WK. Chemoprevention of cancer. CA Cancer J Clin. 2004;54:150\u2013180.", "ArticleIdList": ["15195789"]}, {"Citation": "Olinski R, Gackowski D, Foksinski M, Rozalski R, Roszkowski K, Jaruga P. Oxidative DNA damage: assessment of the role in carcinogenesis, artherosclerosis, and acquired immunodeficiency syndrome. Free Radic Biol Med. 2002;33:192\u2013200.", "ArticleIdList": ["12106815"]}, {"Citation": "Owuor ED, Kong AN. Antioxidants and oxidants regulated signal transduction pathways. Biochem Pharmacol. 2002;64:765\u2013770.", "ArticleIdList": ["12213568"]}, {"Citation": "Nakae D, Umemura T, Kurokawa Y. Reactive oxygen and Nitrogen Oxide Species-induced stress, a Major Intrinsic Factor involved in Carcinogenesic Processes and a Possible Target for Cancer Prevention. Asian Pac J cancer Prev. 2002;3:313\u2013318.", "ArticleIdList": ["12716289"]}, {"Citation": "Oshima H. Genetic and epigenetic damage induced by reactive nitrogen species: implications in carcinogenesis. Toxicol Lett. 2003;140\u2013141:99\u2013104.", "ArticleIdList": ["12676455"]}, {"Citation": "Steinmetz, Kristi A, Potter, John D. Vegetables, fruit, and cancer prevention. J American Diet Assoc. 1996;96:1\u201318.", "ArticleIdList": ["8841165"]}, {"Citation": "Sporn MB, Suh N. Chemoprevention of cancer. Carcinogenesis. 2000;21:525\u2013530.", "ArticleIdList": ["10688873"]}, {"Citation": "Talalay P, Fahey JW. Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr. 2001;131:3027S\u20133033S.", "ArticleIdList": ["11694642"]}, {"Citation": "Van Meeteren ME, Hendriks JJ, Dijkstra CD, Van Tol EA. Dietary compounds prevent oxidative damage and nitric oxide production by cells involved in demyelinating disease. Biochem Pharmacol. 2004;67:967\u2013975.", "ArticleIdList": ["15104250"]}, {"Citation": "Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (\u2212)-epigallocatechin-3-gallate. Cancer Res. 2006;66:2500\u20132505.", "ArticleIdList": ["16510563"]}, {"Citation": "Hou DX. Potential mechanisms of cancer chemoprevention by anthocyanins. Current Molecular Medicine. 2003;3:149\u2013159.", "ArticleIdList": ["12630561"]}, {"Citation": "Jannin B, Menzel M, Berlot JP, Delmas D, Lancon A, Latruffe N. Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: Plasmatic protein binding and cell uptake. Biochem Pharmacol. 2004;68:1113\u20131118.", "ArticleIdList": ["15313407"]}, {"Citation": "Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW, Weinstein IB. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol. 2002;2:350\u2013359.", "ArticleIdList": ["12440226"]}, {"Citation": "Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene. 2003;22:4851\u20134859.", "ArticleIdList": ["12894226"]}, {"Citation": "Surh YJ. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: A short review. Food Chem Toxicol. 2002;40:1091\u20131097.", "ArticleIdList": ["12067569"]}, {"Citation": "Johnson EJ. The role of carotenoids in human health. Nutr Clin Care. 2002;5:56\u201365.", "ArticleIdList": ["12134711"]}, {"Citation": "Gner KH, Elmadfa I. Biological relevance of terpenoids. Overview focusing on mono- di- and tetraterpenes. Ann Nutr Metab. 2003;47:95\u2013106.", "ArticleIdList": ["12743459"]}, {"Citation": "Honda T, Rounds BV, Gribble GW, Suh N, Wang Y, Sporn MB. Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophases. Bioorg Med Chem Lett. 1998;8:271\u2013274.", "ArticleIdList": ["9873608"]}, {"Citation": "Suh N, Wang Y, Honda T. A novel synthetic oleanane triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating antiproliferative and anti-inflammatory activity. Cancer Res. 1999;39:326\u2013341.", "ArticleIdList": ["9927043"]}, {"Citation": "Kelloff GJ, Hawk ET, Karp JE. Progress in clinical chemoprevention. Semin Oncol. 1997;24:241\u2013252.", "ArticleIdList": ["9129692"]}, {"Citation": "Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, Hayes RB. Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst. 2007;99:1200\u20131209.", "ArticleIdList": ["17652276"]}, {"Citation": "Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control. 1991;2:325\u2013357.", "ArticleIdList": ["1834240"]}, {"Citation": "Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer. 1992;18:129.", "ArticleIdList": ["1408943"]}, {"Citation": "Grassmann J. Terpenoids as plant antioxidants. Vitam Horm. 2005;72:505\u2013535.", "ArticleIdList": ["16492481"]}, {"Citation": "Krinsky NI, Johnson EJ. Carotenoid actions and their relation to health and disease. Mol Aspects Med. 2005;26:459\u2013516.", "ArticleIdList": ["16309738"]}, {"Citation": "Govannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst. 1999;91:317\u2013331.", "ArticleIdList": ["10050865"]}, {"Citation": "Campbell J, Canene-Adams K, Lindshield B, Boileau T, Clinton S, Erdman JW. Tomato phytochemicals and prostate cancer risk. J Nutr. 2004;134:3486S\u20133493S.", "ArticleIdList": ["15570058"]}, {"Citation": "Crowell PL. Prevention and therapy of cancer by dietary monoterpenes. J Nutr. 1999;129:775S\u2013778S.", "ArticleIdList": ["10082788"]}, {"Citation": "Egbede JA, Elson CE, Qureshi A, Tanner MA, Gould MN. Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene. Carcinogenesis. 1984;5:661\u2013664.", "ArticleIdList": ["6426810"]}, {"Citation": "Bardon S, Picard K, Martel P. Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines. Nutr Cancer. 1998;32:1\u20137.", "ArticleIdList": ["9824849"]}, {"Citation": "Elegbede JA, Elson CE, Tanner MA, Qureshi A, Gould MN. Regression of rat mammary tumors following dietary d-limonene. J Natl Cancer Inst. 1986;76:323\u2013325.", "ArticleIdList": ["3080636"]}, {"Citation": "Crowell PL, Kennan WS, Haag JD. Identification of metabolites of the antitumor agent d-limonene capable of inhibiting protein isoprenylation and cell growth. Cancer Chemother Pharmacol. 1992;31:205\u2013212.", "ArticleIdList": ["1464157"]}, {"Citation": "Chang BH, Lee HY, Lee JS, Young CY. Perillyl alcohol inhibits the expression and function of the androgen receptor in human prostate cancer cells. Cancer Lett. 2006;236:222\u2013228.", "ArticleIdList": ["16029925"]}, {"Citation": "Kawata S, Nagas T, Yamasaki E, Ishiguro H, Matsuzawa Y. Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2) Br J Cancer. 1994;69:1015\u20131020.", "ArticleIdList": ["PMC1969414", "8198962"]}, {"Citation": "Belanger JT. Perillyl alcohol: applications in oncology. Altern Med Rev. 1998;3:448\u2013457.", "ArticleIdList": ["9855569"]}, {"Citation": "Brudnak M. Cancer preventing properties of essential oil monoterpenes D-Limonene and Perillyl alcohol. Complementary Medicine Magazine. :1\u20138."}, {"Citation": "Von Burg R. Limonene. J Appl Toxicol. 1995;15:495\u2013499.", "ArticleIdList": ["8603937"]}, {"Citation": "Nakaizumi A, Baba M, Uehara H, Iishi H, Tatsuta M. d-Limonene inhibits N-nitrosobis (2-oxoprenyl) amine induced hamster pancreatic carcinogenesis. Cancer Lett. 1997;117:99\u2013103.", "ArticleIdList": ["9233838"]}, {"Citation": "Jde SF, Carvalho PC, Gattass CR, Paschoal EM, da Mota MS, Silva e, Carvalho Mda G. Effects of perillyl alcohol and heat shock treatment in gene expression of human lung adenocarcinoma cell line A549. J Exp Ther Oncol. 2006;5(4):301\u2013307.", "ArticleIdList": ["17024970"]}, {"Citation": "Kaji I, Tatsuta M, Ishi H, Baba M, Inoue A, Kasuga H. Inhibition by D-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21 RAS plasma membrane association. Int J Cancer. 2001;93:441\u2013444.", "ArticleIdList": ["11433412"]}, {"Citation": "Trokhan S, Gupta S. Anti-proliferative effects of d-Limonene on human prostate carcinoma cells. Proc Amer Asso Cancer Res. 2003;44:1094."}, {"Citation": "Chen J, Lu M, Jing Y, Dong J. The synthesis of L-carvone and limonene derivatives with increased antiproliferative effect and activation of ERK pathway in prostate cancer cells. Bioorganic & Medicinal Chemistry. 2006;14:6539\u20136547.", "ArticleIdList": ["16806947"]}, {"Citation": "Rajesh D, Howard S. Perillyl alcohol mediated radiosensitization via augmentation of the Fas pathway in prostate cancer cells. Prostate. 2003;57:14\u201323.", "ArticleIdList": ["12886519"]}, {"Citation": "Chung BH, Lee HY, Lee JS, Young CYF. Perillyl alcohol inhibits the expression and function of the androgen receptor in human prostate cancer cells. Cancer Lett. 2006;236:222\u2013228.", "ArticleIdList": ["16029925"]}, {"Citation": "Ripple GH, Gould MN, Arzoomanian RZ, Alberti D, Feierabend C, Simon K, Binger K, Tutsch KD, Pomplun M, Wahamaki A, Marnocha R, Wilding G, Bailey HH. Phase I clinical and pharmacokinetic study of Perillyl alcohol administered four times a day. Clin Cancer Res. 2000;6:390\u2013396.", "ArticleIdList": ["10690515"]}, {"Citation": "Liu G, Oettel K, Bailey H, Ummersen LV, Tutsch K, Staab MJ, Horvath D, Arzoomanian R, Rezazadeh H, McGovern J, Robinson E, DeMets D, Wilding G. Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer. Invest New Drugs. 2003;21:367\u201372.", "ArticleIdList": ["14578686"]}, {"Citation": "del Bano MJ, Lorente J, Castillo J, Benavente-Garcia O, del Rio JA, Ortuno A, Quirin KW, Gerard D. Phenolicditerpenes, flavones, and rosmarinic acid distribution during the development of leaves, flowers, stems, and roots of Rosmarinus officinalis. Antioxidant activity. J Agric Food Chem. 2003;51:4247\u20134253.", "ArticleIdList": ["12848492"]}, {"Citation": "Lippman SM, Kessle JF, Meyskens FL. Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep. 1987;71:391\u2013405.", "ArticleIdList": ["3548957"]}, {"Citation": "Goodman DS. Overview of current knowledge of metabolism of vitamin A and carotenoids. J Natl Cancer Inst. 1984;73:1375\u20131380.", "ArticleIdList": ["6096622"]}, {"Citation": "Sporn MB, Roberts AB. The role of retinoids in differentiation and carcinogenesis. Cancer Res. 1983;43:3034\u20133040.", "ArticleIdList": ["6189589"]}, {"Citation": "Hong WK, Lippman SM, Itri LL. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med. 1990;323:795\u2013801.", "ArticleIdList": ["2202902"]}, {"Citation": "Sporn MB, Dunlop NM, Newton DL, Smith JM. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogues (retinoids) Fed Proceed. 1976;35:1332\u20131338.", "ArticleIdList": ["770206"]}, {"Citation": "Chambon P. The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol. 1994;5:115\u2013125.", "ArticleIdList": ["8068884"]}, {"Citation": "Glass CK, DiRenzo J, Kurokawa R, Han ZH. Regulation of gene expression by retinoic acid receptors. DNA Cell Biol. 1991;10:623\u2013638.", "ArticleIdList": ["1661598"]}, {"Citation": "de The H, Vivanco-Ruiz MM, Triollais P, Stunnerberg H, Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor \u03b2 gene. Nature. 1990;343:177\u2013180.", "ArticleIdList": ["2153268"]}, {"Citation": "Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell. 1995;83:841\u2013850.", "ArticleIdList": ["8521508"]}, {"Citation": "Schuman LM, Mandell JS, Radke A, Seal U, Halberg F. some selected features of the epidemiology of prostatic cancer. Minneapolis-St. Paul, Minnesota case-control study, 1976\u20131979. In: Magnus K, editor. Trends in Cancer Incidence: Causes and Practical Implications. Hemisphere Publishing; Washngton, D.C: 1982. pp. 345\u2013354."}, {"Citation": "Yong LC, Brown CC, Schatzkin A, Dresser CM, Slesinski MJ, Cox CS, Taylor PR. Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. Am J Epidemiol. 1997;146:231\u2013243.", "ArticleIdList": ["9247007"]}, {"Citation": "Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst. 1995;87:1767\u20131776.", "ArticleIdList": ["7473833"]}, {"Citation": "Hirayama T. Epidemiology of prostate cancer with special reference to the role of diet. Natl Cancer Inst Monogr. 1979;53:149\u2013155.", "ArticleIdList": ["537622"]}, {"Citation": "Lippman SM, Kessler JF, Meyskens FL. Retinoids as preventive and therapeutic anticancer agents (Part I) Cancer Treat Rep. 1987;71:391\u2013405.", "ArticleIdList": ["3548957"]}, {"Citation": "Zhong C, Yang S, Huang J, Cohen MB, Roy-Burman P. Aberration in the expression of the retinoid receptor, RXR\u03b1, in prostate cancer. Cancer Biol Ther. 2003;2:179\u2013184.", "ArticleIdList": ["12750559"]}, {"Citation": "Gediya LK, Chopra P, Purushotta Machar P, Maheshwari N, Njar VC. A new simple and high-yield synthesis of suberoylanilide hydroxamic acid and its inhibitory effect alone or in combination with retinoids on proliferation of human prostate cancer cells. J Med Chem. 2005;28:5047\u20135051.", "ArticleIdList": ["16033284"]}, {"Citation": "Jin F, Liu X, Zhou Z, Yue P, Lotan R, Khuri FR, Chung LW, Sun SY. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells. Cancer Res. 2005;65:6354\u20136363.", "ArticleIdList": ["16024638"]}, {"Citation": "Webber MM, Waghray A. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid. Clin Cancer Res. 1995;1:755\u2013761.", "ArticleIdList": ["9816042"]}, {"Citation": "Liang JY, Fontana JA, Rao JN, Ordonez JV, Dawson MI, Shroot B, Wilber JF, Feng P. Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3. Prostate. 1999;38:228\u2013236.", "ArticleIdList": ["10068347"]}, {"Citation": "Buletic Z, Soprano KJ, Soprano DR. Retinoid targets for the treatment of cancer. Crit Rev Eukaryot Gene Expr. 2006;16:193\u2013210.", "ArticleIdList": ["17073551"]}, {"Citation": "Cheema SK, Mishra SK, Rangnekar VM, Tari AM, Kumar R, Lopez-Berestein G. Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter. J Biol Chem. 2003;278:19995\u201320005.", "ArticleIdList": ["12644474"]}, {"Citation": "Pollard M, Luckert P, Sporn M. Prevention of primary prostate cancer in Loblund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res. 1991;51:3610\u20133611.", "ArticleIdList": ["1829024"]}, {"Citation": "Wang Q, Weider R. All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cells. Oncogene. 2004;23:426\u2013433.", "ArticleIdList": ["14724571"]}, {"Citation": "Costa A, Formelli F, Chiesa F, Decensi A, De Palo G, Veronesi U. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res (Suppl) 1994;54:2032s\u20132037s.", "ArticleIdList": ["8137334"]}, {"Citation": "Kamm JJ, Ashenfelter KO, Ehmann CW. Preclinical and clinical toxicity of selected retinoids. In: Sporn MB, Roberts AB, Goodman D, editors. The Retinoids. Academic Press; NY: 1984. pp. 287\u2013326."}, {"Citation": "Young CW, Warrell RP. Differentiating Agents. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer Principles and Practive of Oncology. 4. J. B. Lippincott; Philadelphia: 1993. pp. 2636\u20132646."}, {"Citation": "Beveridge TH, Li TS, Drover JC. Phytosterol content in American ginseng seed oil. J Agric Food Chem. 2002;50:744\u2013750.", "ArticleIdList": ["11829639"]}, {"Citation": "Kakuda R, Iijima T, Yaolta Y, Machida K, Kikuchi M. Triterpenoids from. Gentiana scabra Phytochem. 2002;59:791\u2013794.", "ArticleIdList": ["11937156"]}, {"Citation": "Hasmeda M, Kweifio-Okai G, Macrides T, Polya GM. Selective inhibition of eukaryote protein kinases by anti-inflammatory triterpenoids. Planta Med. 1999;65:14\u20138.", "ArticleIdList": ["10083838"]}, {"Citation": "Rajic A, Kweifio-Okai G, Macrides T, Sandeman RM, Chandle DS, Polya GM. Inhibition of serine proteases by anti-inflammatory triterpenoids. Planta Med. 2000;66:206\u2013210.", "ArticleIdList": ["10821043"]}, {"Citation": "Geetha T, Varalakshmi P. Anti-inflammatory activity of lupeol and lupeol linoleate in rats. J Ethnopharmacol. 2001;76:77\u201380.", "ArticleIdList": ["11378285"]}, {"Citation": "Moriarity DM, Huang J, Yancey CA. Lupeol is the cytotoxic principle in the leaf extract of Dendropanax cf. quercetin. Planta Med. 1998;64:370\u2013372.", "ArticleIdList": ["9619122"]}, {"Citation": "Saleem M, Alam A, Arifin S, Shah MS, Ahmed B, Sultana S. Lupeol, a triterpene, inhibits early responses of tumor promotion induced by benzoyl peroxide in murine skin. Pharmacol Res. 2001;43:127\u2013134.", "ArticleIdList": ["11243713"]}, {"Citation": "Hodges LD, Kweifio-Okai G, Macrides TA. Antiprotease effect of anti-inflammatory lupeol esters. Mol Cell Biochem. 2003;252:97\u2013101.", "ArticleIdList": ["14577581"]}, {"Citation": "Wada S, Iida A, Tanaka R. Triterpene constituents from the stem barks of Pinus luchuensis and their DNA topoisomerase II inhibitory effect. Planta Med. 2001;67:659\u2013664.", "ArticleIdList": ["11582546"]}, {"Citation": "Saleem M, Kweon MH, Yun JM, Adhami VM, Khan N, Syed DN, Mukhtar H. A novel dietary triterpene Lupeol induces Fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Cancer Res. 2005;65:11203\u201311213.", "ArticleIdList": ["16322271"]}, {"Citation": "Chintharipalli S, Papineni S, Ramiah SK, Safe S. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res. 2007;67:2816\u20132823.", "ArticleIdList": ["17363604"]}, {"Citation": "Rabi T, Zhang A, Gupta S. Research ShowCASE. Case Western Reserve University; 2007. Betulinic acid: A new potential agent against human prostate cancer; p. 378."}, {"Citation": "Sen CK, Khanna S, Roy S. Tocotrienols: Vitamin E beyond tocopherols. Life Sci. 2006;78:2088\u20132098.", "ArticleIdList": ["PMC1790869", "16458936"]}, {"Citation": "Goh SH, Hew NF, Norhanom AW, Yadav M. inhibition of tumor promotion by various palm-oil tocotrienols. Int J Cancer. 1994;57:529\u2013531.", "ArticleIdList": ["8181855"]}, {"Citation": "Conte C, Floridi A, Aisa C, Piroddi M, Floridi A, Galli F. Gamma-tocotrienol metabolism and aqntiproliferative effect in prostate cancer cells. Ann NY Acad Sci. 2004;1031:391\u2013394.", "ArticleIdList": ["15753178"]}, {"Citation": "Gunawardena K, Murray DK, Meikle AW. Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis. Prostate. 2000;44:287\u2013295.", "ArticleIdList": ["10951493"]}, {"Citation": "Rodrigo R, Guichard C, Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam Clin Pharmacol. 2007;21:111\u2013127.", "ArticleIdList": ["17391284"]}, {"Citation": "Sung L, Greenberg ML, Koren G, Tomilinson GA, Tong A, Malkin D, Feldman BM. Vitamin E: the evidence for multiple roles in cancer. Nutr Cancer. 2003;46:1\u201314.", "ArticleIdList": ["12925298"]}, {"Citation": "Brigelius-Flohe R, Kelly FJ, Salomen JT, Neuzil J, Zingg JM, Azzi A. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr. 2002;76:703\u2013716.", "ArticleIdList": ["12324281"]}, {"Citation": "Fleshner E, Fair WR, Huryk R. Vitamin E inhibits the high fat diet promoted growth of established human prostate LNCaP tumors in nude mice. J Urol. 1999;161:1651\u20131654.", "ArticleIdList": ["10210433"]}, {"Citation": "Meydani M. Vitamin E. Lancet. 1995;345:170\u2013175.", "ArticleIdList": ["7823675"]}, {"Citation": "Eicholzer M, Stalielin HB, Gey KF, Ludin E, Bernasconi F. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer. 1996;66:145\u2013150.", "ArticleIdList": ["8603802"]}, {"Citation": "Halliwell B, Rafter J, Jenner A. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am J Clin Nutr. 2005;81:268S\u2013276S.", "ArticleIdList": ["15640490"]}, {"Citation": "Jiang Q, Christen S, Shigenaga MK, Ames BN. gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr. 2001;74:714\u2013722.", "ArticleIdList": ["11722951"]}, {"Citation": "Jiang Q, Elson-Schwah I, Courtemanche C, Ames BN. gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci USA. 2000;97:11494\u201311499.", "ArticleIdList": ["PMC17228", "11005841"]}, {"Citation": "Jiang Q, Ames BN. Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J. 2003;17:816\u2013822.", "ArticleIdList": ["12724340"]}, {"Citation": "Cooney RV, Franke AA, Harwood PJ, Hatch-Pigott V, Custe LJ, Mordan LJ. Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol. Proc Natl Acad Sci USA. 1993;90:1771\u20131775.", "ArticleIdList": ["PMC45961", "8446589"]}, {"Citation": "Cooney RV, Harwood PJ, Franke AA, Narala K, Sundstrom AK, Berggren PO, Mordan LJ. Products of gamma-tocopherol reaction with NO2 and their formation in rat insulinoma (RINm5F) cells. Free Radical Biol Med. 1995;19:259\u2013269.", "ArticleIdList": ["7557540"]}, {"Citation": "Christen S, Woodall AA, Shigenaga MK, Southwell-Keely PT, Duncan MW, Ames BN. gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci USA. 1997;94:3217\u20133222.", "ArticleIdList": ["PMC20349", "9096373"]}, {"Citation": "Himmelfarb J, Kane J, McMonogle E, Zaltas E, Bobzin S, Boddupalli S, Phinney S, Miller G. Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int. 2003;64:978\u2013991.", "ArticleIdList": ["12911548"]}, {"Citation": "Helzlsouer KJ, Huang HY, Allerg AJ, Hoffman S, Burke A, Norkus EP, Morris JS, Comstick GW. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst. 2000;92:2018\u20132023.", "ArticleIdList": ["11121464"]}, {"Citation": "Galli F, Stable AM, Berti M, Conte C, Pistilli A, Rende M, Floridi A, Azzi A. The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation. Arch Biochem Biophys. 2004;423:97\u2013102.", "ArticleIdList": ["14871472"]}, {"Citation": "Gysin R, Azzi A, Visarius T. Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J. 2002:1952\u20131954.", "ArticleIdList": ["12368234"]}, {"Citation": "Srivastava JK, Gupta S. Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun. 2006;346:447\u2013453.", "ArticleIdList": ["16762318"]}, {"Citation": "Okabe M, Oji M, Ikeda I, Tachbana H, Yamada K. Tocotrienol levels in various tissues of Sprague-Dawley rats after intragastric administration of tocotrienols. Biosc Bioctechnol Biochem. 2002;66:1768\u20131771.", "ArticleIdList": ["12353645"]}, {"Citation": "Burton GW, Traber MG, Acuff RV, Walters DN, Kayden L, Hughes L, Ingold KU. Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. Am J Clin Nutr. 1998;67:669\u2013684.", "ArticleIdList": ["9537614"]}, {"Citation": "Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C. SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial. J Urol. 2001;166:1311\u20131315.", "ArticleIdList": ["11547064"]}, {"Citation": "Krinsky NI, Johnson EJ. Carotenoid actions and their relation to health and disease. Mol Aspects Med. 2005;26:459\u2013516.", "ArticleIdList": ["16309738"]}, {"Citation": "Keijer J, Bunschoten A, Palou A, Franssen-van Hal NL. Beta-carotene and the application of transcriptomics in risk-benefit evaluation of natural dietary components. Biochim Biophys Acta. 2005;1740:139\u2013146.", "ArticleIdList": ["15949680"]}, {"Citation": "Peters U, Leitzmann ME, Chatterjee N, Wang Y, Albanes D, Gelmann EP, Friesen MD, Riboli E, Hayes RB. Serum lycopene, other carotenoids and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Rev. 2007;16:962\u2013968.", "ArticleIdList": ["17507623"]}, {"Citation": "Gerster H. The potential role of lycopene for human health. J Am Coll Nutr. 1997;16:109\u2013126.", "ArticleIdList": ["9100211"]}, {"Citation": "Stahl W, Seis H. Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys. 1996;336:1\u20139.", "ArticleIdList": ["8951028"]}, {"Citation": "Clinton SK, Emenhiser C, Schwartz SJ. Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate cancer patients. Cancer Epidemiol Biomarkers Prev. 1996;5:823\u2013833.", "ArticleIdList": ["8896894"]}, {"Citation": "Vogt TM, Mayne ST, Graubard BI, Swanson CA, Sowell AL, Schoenberg JB, Swanson GM, Greensberg RS. Serum lycopene, other serum carotenoids, and risk of prostate cancer in US blacks and whites. Am J Epidemiol. 2002;155:1023\u20131032.", "ArticleIdList": ["12034581"]}, {"Citation": "Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst. 2002;94:391\u2013398.", "ArticleIdList": ["11880478"]}, {"Citation": "Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MN, Khachik F, Banerjee M, Bertram JS, Wood DP., Jr Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med (Maywood) 2002;227:881\u2013885.", "ArticleIdList": ["12424329"]}, {"Citation": "Bowen P, Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, Kim HS, Christov-Tzelkov K, van Breemen RB. Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med (Maywood) 2002;227:886\u2013893.", "ArticleIdList": ["12424330"]}, {"Citation": "van Breemen RB, Xu X, Viana MA, Chen L, Stacewicz-Sapuntzakis M, Duncan C, Bowen PE, Sharifi R. Liquid chromatography-mass spectrometry of cis- and all-trans-lycopene in human serum and prostate tissue after dietary supplementation with tomato sauce. J Agric Food Chem. 2002;50:2214\u20132219.", "ArticleIdList": ["11929273"]}, {"Citation": "Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ, Erdman JW., Jr cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev. 1996;5:823\u2013833.", "ArticleIdList": ["8896894"]}, {"Citation": "Clark PE, Hall MC, Borden LS, Jr, Miller AA, Hu JJ, Lee WR, Stindt D, D\u2019Agostino R, Jr, Lovato J, Harmon M, FM Phase I\u2013II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. Urology. 2006;67:1257\u20131261.", "ArticleIdList": ["16765186"]}, {"Citation": "Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, Li YW, Banerjee M, Grignon D, Bertram JS, Crissman JD, Pontes EJ, Wood DP., Jr Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev. 2001;10:861\u2013868.", "ArticleIdList": ["11489752"]}, {"Citation": "Greenwald P, Wikin KM, Malone WF, Byar DP, Freedman LS, Stern HR. The study of markers of biological effects in cancer prevention research trials. Int J Cancer. 1992;82:555\u2013560.", "ArticleIdList": ["1521908"]}, {"Citation": "Stadtzkin A, Freedman LS, Stern HR. Surrogate end points in cancer research: a critique. Cancer Epidemiol Biomarkers Prev. 1996;5:947\u2013953.", "ArticleIdList": ["8959315"]}, {"Citation": "Bostwick DG, Burke HB, Wheeler TM. The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostate adenocarcinoma in short-term phase II clinical trials. J Cell Biochem. 1994;19:283\u2013289.", "ArticleIdList": ["7529857"]}, {"Citation": "Bostwick DG. Prostatic intraepithelial neoplasia is a risk factor for cancer. Semin Urol Oncol. 1999;17:187\u2013198.", "ArticleIdList": ["10632120"]}, {"Citation": "Lippman SM, Lotan R. Advances in the development of retinoids as chemopreventive agents. J Nutr. 2000;130:479S\u2013482S.", "ArticleIdList": ["10721933"]}, {"Citation": "Tsai H, Werber M, Davia O, Edelman KE, Tanaka E, Melman A, Christ J, Geliebtor J. Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells. Biochem Biophys Res Commun. 1996;22:64\u201369.", "ArticleIdList": ["8858104"]}, {"Citation": "Pollak M, Beamer W, Zhang JC. Insulin-like growth factors and prostate cancer. Cancer Met Rev. 1998;17:383\u2013390.", "ArticleIdList": ["10453282"]}, {"Citation": "Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN. gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci USA. 2000;97:11494\u201311499.", "ArticleIdList": ["PMC17228", "11005841"]}, {"Citation": "Himmelfarb J, Kane J, McMonagle E, Zaltas E, Bobzin S, Boddupalli S, Phinney S, Miller G. Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int. 2003;64:978\u2013991.", "ArticleIdList": ["12911548"]}, {"Citation": "Kolesnick R. The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest. 2002;110:3\u20138.", "ArticleIdList": ["PMC151041", "12093880"]}, {"Citation": "Solomon JC, Sharma K, Wei L, Fugita T, Shi YF. A novel role for sphingolipid intermediates in activation-induced cell death in T cells. Cell death Differ. 2003;10:193\u2013202.", "ArticleIdList": ["12700647"]}]}], "History": [{"Year": "2008", "Month": "5", "Day": "30", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "9", "Day": "20", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "5", "Day": "30", "Hour": "9", "Minute": "0"}, {"Year": "2014", "Month": "5", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["18508447", "NIHMS578453", "PMC4019960", "10.2741/2940", "2940"]}}], "PubmedBookArticle": []}